Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of mometasone furoate + formoterol versus mometasone furoate in persistent asthma
2011-002142-13Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone, formoterol in persistent asthma, sponsored by Merck & Co.. Started Feb 2012; status: completed.
02
Drugs
mometasoneformoterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2011-002142-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002142-13.